VERACYTE, INC. Operating Lease, Expense
VERACYTE, INC. (VCYT) reported Operating Lease, Expense of $1.77 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-07-31
- VERACYTE, INC. operating lease, expense for the quarter ending 2026-06-30 was $1.77M, a 19.02% decline year-over-year.
- VERACYTE, INC. operating lease, expense for the quarter ending 2026-03-31 was $1.77M, a 21.43% decline year-over-year.
- VERACYTE, INC. operating lease, expense for the quarter ending 2025-12-31 was $1.77M, a 1.20% increase year-over-year.
- VERACYTE, INC. operating lease, expense for the quarter ending 2025-09-30 was $1.91M, a 4.82% increase year-over-year.
- VERACYTE, INC. operating lease, expense for fiscal 2025 was $8.05M, a 20.71% increase from fiscal 2024.
- VERACYTE, INC. operating lease, expense for fiscal 2024 was $6.67M, a 26.65% increase from fiscal 2023.
- VERACYTE, INC. operating lease, expense for fiscal 2023 was $5.26M, a 19.88% increase from fiscal 2022.
- VERACYTE, INC. operating lease, expense for fiscal 2022 was $4.39M, a 25.38% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed | Operating Lease, Expense 21 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.77M 10-Q · filed 2026-07-31 | $3.54M 10-Q · filed 2026-07-31 | $5.31M derived: sum of 3 quarters · filed 2026-07-31 | $7.22M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2026-03-31 | $1.77M 10-Q · filed 2026-05-06 | $3.55M derived: sum of 2 quarters · filed 2026-05-06 | $5.46M derived: sum of 3 quarters · filed 2026-05-06 | $7.64M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.69M derived: sum of 2 quarters · filed 2026-02-26 | $5.87M derived: sum of 3 quarters · filed 2026-07-31 | $8.05M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $1.91M 10-Q · filed 2025-11-05 | $4.09M derived: sum of 2 quarters · filed 2026-07-31 | $6.27M 10-Q · filed 2025-11-05 | $8.10M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-06-30 | $2.18M 10-Q · filed 2026-07-31 | $4.36M 10-Q · filed 2026-07-31 | $6.19M derived: sum of 3 quarters · filed 2026-07-31 | $8.01M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-03-31 | $2.25M 10-Q · filed 2026-05-06 | $4.01M derived: sum of 2 quarters · filed 2026-05-06 | $5.83M derived: sum of 3 quarters · filed 2026-05-06 | $7.25M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.58M derived: sum of 2 quarters · filed 2026-02-26 | $5.00M derived: sum of 3 quarters · filed 2026-02-26 | $6.67M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $1.82M 10-Q · filed 2025-11-05 | $3.25M derived: sum of 2 quarters · filed 2025-11-05 | $4.91M 10-Q · filed 2025-11-05 | $6.22M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $1.42M 10-Q · filed 2025-08-07 | $2.96M 10-Q · filed 2025-08-07 | $4.40M derived: sum of 3 quarters · filed 2026-02-26 | $5.83M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $1.54M 10-Q · filed 2025-05-08 | $2.98M derived: sum of 2 quarters · filed 2026-02-26 | $4.41M derived: sum of 3 quarters · filed 2026-02-26 | $5.68M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.86M derived: sum of 2 quarters · filed 2026-02-26 | $4.14M derived: sum of 3 quarters · filed 2026-02-26 | $5.26M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $1.43M 10-Q · filed 2024-11-07 | $2.71M derived: sum of 2 quarters · filed 2024-11-07 | $3.83M 10-Q · filed 2024-11-07 | $4.95M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $1.28M 10-Q · filed 2024-08-07 | $2.40M 10-Q · filed 2024-08-07 | $3.52M derived: sum of 3 quarters · filed 2025-02-28 | $4.63M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $1.12M 10-Q · filed 2024-05-08 | $2.24M derived: sum of 2 quarters · filed 2025-02-28 | $3.35M derived: sum of 3 quarters · filed 2025-02-28 | $4.46M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $2.23M derived: sum of 2 quarters · filed 2025-02-28 | $3.34M derived: sum of 3 quarters · filed 2025-02-28 | $4.39M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $1.10M 10-Q · filed 2023-11-08 | $2.22M derived: sum of 2 quarters · filed 2023-11-08 | $3.27M 10-Q · filed 2023-11-08 | $4.32M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $1.11M 10-Q · filed 2023-08-09 | $2.17M 10-Q · filed 2023-08-09 | $3.21M derived: sum of 3 quarters · filed 2024-02-29 | $4.19M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $1.05M 10-Q · filed 2023-05-05 | $2.10M derived: sum of 2 quarters · filed 2024-02-29 | $3.08M derived: sum of 3 quarters · filed 2024-02-29 | $3.98M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.02M derived: sum of 2 quarters · filed 2024-02-29 | $2.93M derived: sum of 3 quarters · filed 2024-02-29 | $3.50M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $982.00K 10-Q · filed 2022-11-03 | $1.88M derived: sum of 2 quarters · filed 2022-11-03 | $2.46M 10-Q · filed 2022-11-03 | $2.93M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $902.00K 10-Q · filed 2022-08-03 | $1.48M 10-Q · filed 2022-08-03 | $1.95M derived: sum of 3 quarters · filed 2023-03-01 | $2.42M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $575.00K 10-Q · filed 2022-05-04 | $600.00K 10-Q · filed 2021-05-10 | $1.05M derived: sum of 2 quarters · filed 2023-03-01 | $1.52M derived: sum of 3 quarters · filed 2023-03-01 | $1.99M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $472.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $944.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.42M derived: sum of 3 quarters · filed 2023-03-01 | $1.89M 10-K · filed 2023-03-01 | $1.90M 10-K · filed 2021-02-22 | |||
| 2020-09-30 | $472.00K 10-Q · filed 2021-11-09 | $500.00K 10-Q · filed 2020-11-02 | $944.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.42M 10-Q · filed 2021-11-09 | $1.94M derived: sum of 4 quarters · filed 2022-02-28 | $1.40M 10-Q · filed 2020-11-02 | ||
| 2020-06-30 | $472.00K 10-Q · filed 2021-07-29 | $500.00K 10-Q · filed 2020-07-30 | $944.00K 10-Q · filed 2021-07-29 | $1.00M 10-Q · filed 2020-07-30 | $1.47M derived: sum of 3 quarters · filed 2022-02-28 | $1.97M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | $500.00K 10-Q · filed 2021-05-10 | $474.00K 10-Q · filed 2020-05-06 | $999.00K derived: sum of 2 quarters · filed 2022-02-28 | $1.50M derived: sum of 3 quarters · filed 2022-02-28 | $2.00M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $499.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $999.00K derived: sum of 2 quarters · filed 2022-02-28 | $1.50M derived: sum of 3 quarters · filed 2022-02-28 | $1.90M 10-K · filed 2022-02-28 | $1.90M 10-K · filed 2020-02-25 | |||
| 2019-09-30 | $500.00K 10-Q · filed 2020-11-02 | $1.00M derived: sum of 2 quarters · filed 2020-11-02 | $1.40M 10-Q · filed 2020-11-02 | |||||
| 2019-06-30 | $500.00K 10-Q · filed 2020-07-30 | $1.00M 10-Q · filed 2020-07-30 | ||||||
| 2019-03-31 | $476.00K 10-Q · filed 2020-05-06 | |||||||
| 2018-12-31 | $1.90M 10-K · filed 2021-02-22 | |||||||
| 2017-12-31 | $1.90M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |